CYP2D6 and Schnyder corneal dystrophy: The experience in cancer will probably guide the research efforts concerning SCD, as demonstrated by the study by Gammal et al. [194], who discussed the role of pharmacogenomics (in particular focusing on the CYP2D6 genotype for the safe use of codeine in SCD).